Investment analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded shares of Onconova Therapeutics from a “neutral” rating to a “buy” rating and set a $11.00 price target on […]